News

CHDS Faculty Ankur Pandya, Uwe Siebert, and Myriam Hunink joined colleagues in recommending directed acyclic graphs (DAGs) in Decision-Analytic Modeling in a recent Medical Decision Making

Maria (Myriam) Hunink, MD, PhD was honored for her career achievements at a symposium and celebratory event held at the Nieuwe Instituut, Rotterdam, the Netherlands last month.

Benefit-cost analysis is well-established and widely used to inform policy decisions. Its normative foundations are explored in “Ethics and Benefit-Cost Analysis,” a special issue of the Journal of Benefit

CHDS’s Ole Norheim served as one of the editors to the fourth edition of the Disease Control Priorities (DCP-4) Country-Led Priorities Setting for Health volume, released last month. This is the first of four volumes

Conventional methods for valuing health and longevity have several well-known limitations. In a CHDS seminar, Maddalena Ferranna discussed social welfare function analysis

CHDS’ Nicolas Menzies recently participated in a panel discussion on Advances in Genomic Surveillance and Tuberculosis Diagnosis, hosted by Harvard T.H. Chan School of Public Health.

CHDS Faculty Zachary Ward will present a new course this spring geared to doctoral and advanced masters students: Advanced Computational Methods for Disease Modeling. This is an advanced course

CHDS’ James Hammitt recently participated in the Symposium on Valuing Life and Health, sponsored by the Australian National University. The symposium brought together expert policy

CHDS’ Zachary Ward and colleagues assessed the causes of the UK’s poor rate of cancer survival compared with other high income countries, in a recent Lancet Oncology commentary.

CHDS faculty Thomas Gaziano presented Meeting the United Nations Goal of Reducing Premature Cardiovascular Disease Mortality: Global trends, policies and implementation at a seminar